Effectiveness and Safety of Dolutegravir and Raltegravir for Treating Children and Adolescents Living with HIV

J. Int. AIDS Soc.

These reassuring findings suggest that dolutegravir and raltegravir are effective and safe as preferred regimens in children and adolescents living with HIV. With the rollout of dolutegravir in paediatric populations already underway, it is critical that data are collected on safety and effectiveness in infants, children and adolescents, including on longer-term outcomes, such as weight and metabolic changes.